ArticleBMJ open2024

Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.

Lidia Groele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.